Low-cost carrier, SpiceJet, on Monday announced the signing of a Memorandum of Understanding (MoU) with Pluss Advanced Technologies (PLUSS) for the supply of indigenously developed precise temperature control boxes required of maintaining the effectiveness of the vaccine during transport.
SpiceJet MOU For Celsure®
PLUSS will supply its patented product – Celsure®, developed using its proprietary Phase Change Material technology, for transportation of the Covid-19 vaccines from the manufacturer to different parts of the country. The product will be co-branded especially for SpiceJet’s cargo division Spice Xpress and will be made available at various locations across the country.
While, transporting pharmaceutical products, biological products or vaccines in particular, the need to maintain precise temperature ranges is very important and the efficacy of vaccine can be impacted if the temperature goes above or below the specified range. PLUSS, an India based material solutions company has designed and manufactured a precise temperature-control delivery solution that is required for vaccine delivery to the last mile.
“At PLUSS we have been continuously working towards playing our role in getting India ready to effectively combat the COVID-19 pandemic, once the vaccine is approved for use. We are particularly happy to join forces with SpiceJet to ensure the delivery of the vaccine using the safest and fastest mode. SpiceJet flies to many non-metro locations and that will help the vaccine reach to the rural hinterlands of India,” Samit Jain, MD PLUSS said.
PLUSS: Pioneering Phase Change Material
Sanjiv Gupta, CEO, Spice Jet-Cargo Division said that at Spice Xpress, they were excited about this partnership. “PLUSS has been a pioneer in Phase Change Material based temperature control solutions in India and will be the appropriate partner as we plan on moving the temperature sensitive COVID-19 vaccines across the country,” he said.
Spice Xpress has the biggest cargo fleet with more than 17 flights. “We can cover the length and breadth of the country through our partnerships with last mile logistics companies. We can deliver the vaccines within 48-72 hours to any part of the country and Pluss’ temperature control boxes will play a critical role in ensuring the safety and efficacy of the vaccine” said Mr. Gupta.
PLUSS, funded by Tata Capital Innovation Fund, has made rapid strides in precise temperature control solutions using inhouse R&D and has several award-winning solutions and patents for pharma, building and logistics industries in India and overseas.